AIM: To calculate the epidemiology of Rheumatic Diseases in Iran. MATERIALS AND METHODS: The data of Tehran, Zahedan, Sanandaj (urban) and Tuyserkan (rural) stage Community Oriented Program for the Control of Rheumatic Diseases (COPCORD) studies were gathered. The data were adjusted to the population number of the studied areas to represent Iran. RESULTS: The population of Iran is 75 149 669 (71.5% urban areas, males 50.4%) and of the mentioned area were respectively 10 000 000, 580 071, 311 444 and 109 262. The interviewed subjects were 10 291, 1565, 2100 and 5830. Male/female ratio was 0.9/1, 0.8/1, 08/1 and 0.8/1. Musculoskeletal complaints during the past 7 days (people aged ≥ 15 years) were detected in 44.7% of subjects. They were: shoulder 15.6%, wrist 10.4%, hands and fingers 10.2%, hip 8.3%, knee 27.4%, ankle 12.3%, toes 6.2%, cervical spine 14.2% and dorsolumbar spine 23.7%. Osteoarthritis (OA) was detected in 16.9%: knee 15.5%, hands 2.9% and hip 0.32%. Low back pain was found in 15.7%, sciatica in 0.94%, and soft tissue rheumatism in 4.6% (shoulder tenosynovitis 2.5%, frozen shoulder 0.56%, tennis elbow 1.2%, golf elbow 0.48%, de Quervain tenosynovitis 0.24%, trigger finger 0.2%, carpal tunnel syndrome 1.3%). Rheumatoid arthritis was detected in 0.37%, seronegative spondyloarthropathy in 0.24%, ankylosing spondylitis in 0.12%, systemic lupus erythematosus in 0.06%, Behcet's disease in 0.08%, fibromyalgia in 0.79% and gout in 0.13%. CONCLUSION: Compared to other COPCORD reports (17 countries), Iran gets the following rank: musculoskeletal complaints second, low back pain fourth, osteoarthritis second, knee osteoarthritis third, soft tissue rheumatism sixth, rheumatoid arthritis tenth, seronegative spondyloarthropathies fifth, gout eleventh and fibromyalgia fifth.
AIM: To calculate the epidemiology of Rheumatic Diseases in Iran. MATERIALS AND METHODS: The data of Tehran, Zahedan, Sanandaj (urban) and Tuyserkan (rural) stage Community Oriented Program for the Control of Rheumatic Diseases (COPCORD) studies were gathered. The data were adjusted to the population number of the studied areas to represent Iran. RESULTS: The population of Iran is 75 149 669 (71.5% urban areas, males 50.4%) and of the mentioned area were respectively 10 000 000, 580 071, 311 444 and 109 262. The interviewed subjects were 10 291, 1565, 2100 and 5830. Male/female ratio was 0.9/1, 0.8/1, 08/1 and 0.8/1. Musculoskeletal complaints during the past 7 days (people aged ≥ 15 years) were detected in 44.7% of subjects. They were: shoulder 15.6%, wrist 10.4%, hands and fingers 10.2%, hip 8.3%, knee 27.4%, ankle 12.3%, toes 6.2%, cervical spine 14.2% and dorsolumbar spine 23.7%. Osteoarthritis (OA) was detected in 16.9%: knee 15.5%, hands 2.9% and hip 0.32%. Low back pain was found in 15.7%, sciatica in 0.94%, and soft tissue rheumatism in 4.6% (shoulder tenosynovitis 2.5%, frozen shoulder 0.56%, tennis elbow 1.2%, golf elbow 0.48%, de Quervain tenosynovitis 0.24%, trigger finger 0.2%, carpal tunnel syndrome 1.3%). Rheumatoid arthritis was detected in 0.37%, seronegative spondyloarthropathy in 0.24%, ankylosing spondylitis in 0.12%, systemic lupus erythematosus in 0.06%, Behcet's disease in 0.08%, fibromyalgia in 0.79% and gout in 0.13%. CONCLUSION: Compared to other COPCORD reports (17 countries), Iran gets the following rank: musculoskeletal complaints second, low back pain fourth, osteoarthritis second, knee osteoarthritis third, soft tissue rheumatism sixth, rheumatoid arthritis tenth, seronegative spondyloarthropathies fifth, gout eleventh and fibromyalgia fifth.
Authors: Maziar Moradi-Lakeh; Mohammad H Forouzanfar; Stein Emil Vollset; Charbel El Bcheraoui; Farah Daoud; Ashkan Afshin; Raghid Charara; Ibrahim Khalil; Hideki Higashi; Mohamed Magdy Abd El Razek; Aliasghar Ahmad Kiadaliri; Khurshid Alam; Nadia Akseer; Nawal Al-Hamad; Raghib Ali; Mohammad AbdulAziz AlMazroa; Mahmoud A Alomari; Abdullah A Al-Rabeeah; Ubai Alsharif; Khalid A Altirkawi; Suleman Atique; Alaa Badawi; Lope H Barrero; Mohammed Basulaiman; Shahrzad Bazargan-Hejazi; Neeraj Bedi; Isabela M Bensenor; Rachelle Buchbinder; Hadi Danawi; Samath D Dharmaratne; Faiez Zannad; Maryam S Farvid; Seyed-Mohammad Fereshtehnejad; Farshad Farzadfar; Florian Fischer; Rahul Gupta; Randah Ribhi Hamadeh; Samer Hamidi; Masako Horino; Damian G Hoy; Mohamed Hsairi; Abdullatif Husseini; Mehdi Javanbakht; Jost B Jonas; Amir Kasaeian; Ejaz Ahmad Khan; Jagdish Khubchandani; Ann Kristin Knudsen; Jacek A Kopec; Raimundas Lunevicius; Hassan Magdy Abd El Razek; Azeem Majeed; Reza Malekzadeh; Kedar Mate; Alem Mehari; Michele Meltzer; Ziad A Memish; Mojde Mirarefin; Shafiu Mohammed; Aliya Naheed; Carla Makhlouf Obermeyer; In-Hwan Oh; Eun-Kee Park; Emmanuel Kwame Peprah; Farshad Pourmalek; Mostafa Qorbani; Anwar Rafay; Vafa Rahimi-Movaghar; Rahman Shiri; Sajjad Ur Rahman; Rajesh Kumar Rai; Saleem M Rana; Sadaf G Sepanlou; Masood Ali Shaikh; Ivy Shiue; Abla Mehio Sibai; Diego Augusto Santos Silva; Jasvinder A Singh; Jens Christoffer Skogen; Abdullah Sulieman Terkawi; Kingsley N Ukwaja; Ronny Westerman; Naohiro Yonemoto; Seok-Jun Yoon; Mustafa Z Younis; Zoubida Zaidi; Maysaa El Sayed Zaki; Stephen S Lim; Haidong Wang; Theo Vos; Mohsen Naghavi; Alan D Lopez; Christopher J L Murray; Ali H Mokdad Journal: Ann Rheum Dis Date: 2017-02-16 Impact factor: 19.103